Leger Marketing, company controlled sponsored market research. Syneron Candela, data on file.ĭata on file: SYNERON CANDELA ULTRASHAPE POWER ULTRASOUND ROI comparison. Noninvasive body contouring by focused ultrasound: safety and efficacy of the Contour I device in a multicenter, controlled, clinical study. Teitelbaum SA, Burns JL, Kubota J, et al. A single-center, controlled study to assess the effectiveness and safety of the UltraShape Power® System using U-Sculpt Power transducer for abdominal non-invasive fat reduction. UltraShape Power 510(k) clearance for flanks and thighs (K170370), May 2017.Īmir R. UltraShape Power 510(k) clearance for abdomen (K160896), July 2016. Characterization of nonthermal focused ultrasound for noninvasive selective fat cell disruption (lysis): technical and preclinical assessment. Light handpiece designed to provide precise control while reducing operator fatigueīrown SA, Greenbaum L, Shtukmaster S, Zadok Y, Ben-Ezra S, Kushkuley L. Lightweight, compact design for easy transport between treatment rooms (the entire system weighs just 45 kg/99 lbs.) Candela can help extend your practice’s reach with consumer marketing toolkits and assistance in bringing in patients to your practice.Įnd-to-end patient and therapy management solution offers sophisticated, easy-to-use analysis and reporting toolsīuilt-in HD touchscreen provides ultra-clear visibility and touch control during treatmentįully Wi-Fi enabled for remote diagnostics, software updates, support, and purchasing consumablesĮmbedded tracking system with a built-in, high-definition video cameraįly mode for faster treatment time and higher profitabilityĬomprehensive contouring with a single transducer that precisely focuses ultrasound energy to treat large and small areas Which means you can now offer liposuction candidates a non-invasive alternative.īusiness development support. Syneron Candela stock (past two years) Syneron Candela, the Nasdaq-listed vendor of laser-based medical and aesthetic devices, is set to be sold to private equity giant Apax Partners, in a cash deal valued at close to 400 million. In a recent clinical study, the average reported pain level was 28. It’s a walk-in, walk-out procedure that’s virtually painless. Immediate responses recorded in a clinical study were mild and transient in nature, and completely resolved without intervention within days.3,4 Since UltraShape Power selectively and precisely targets fat cells, blood vessels, nerves, and surrounding tissue are largely unharmed.1 There are no reported cases of lumping, shelving, or other contouring deformities. SYNERON CANDELA ULTRASHAPE POWER ULTRASOUNDįour huge selling points for potential body contouring patients. Autorefractors, Keratometers & Tonometers.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |